LHC Group, Inc. announced a number of corporate governance and board changes that will go into effect with the company's annual shareholder meeting on June 10, 2021. The company announced that W.J. "Billy" Tauzin, will retire from the board, effective June 10, 2021. Effective with the annual shareholder meeting, Clifford S. Holtz, who joined the board in 2018, will become the company's lead independent director. Monica F. Azare, who was first named to the board in 2007, will become chair of the nominating and governance committee. Teri G. Fontenot, who joined the board in 2019, will become chair of the audit committee. Jonathan D. Goldberg, a director since 2018, will become chair of the compensation committee. William Brent Turner, who was first named to the board in 2014, will become chair of the corporate development committee. John L. Indest, a director since 2000, will remain as chair of the clinical quality committee.